Calcitonin in the treatment of intractable pain from advanced malignancy.
AffiliationChristie Hospital, Manchester
MetadataShow full item record
AbstractClinical details are given of 8 patients who complained of severe pain from metastatic bone disease or from multiple myeloma. Four of the patients were included in a double-blind pilot trial designed to compare the effectiveness of salmon calcitonin (200 i.u. intramuscularly) and placebo given twice daily for 4 days. Two of these patients experienced pain relief and were found to have been given salmon calcitonin; the other 2 had no pain relief and had been given placebo. The other 4 of the 8 patients were treated with salmon calcitonin and also had relief of their pain. It would appear, therefore, that salmon calcitonin may be dramatically effective in the treatment of intractable pain from advanced malignancy and its use warrants further study.
CitationCalcitonin in the treatment of intractable pain from advanced malignancy. 1983, 3 (7):482-6 Pharmatherapeutica
- Salmon calcitonin in cancer pain: comparison between two different treatment schedules.
- Authors: Schiraldi GF, Soresi E, Locicero S, Harari S, Scoccia S
- Issue date: 1987 Apr
- [Clinical study of eel calcitonin for relief of pain from metastatic bone lesions].
- Authors: Sasaki F, Uchino J, Hata Y, Sato Y, Konno T, Okuno T, Ohira S, Taguchi K, Fuzisawa J, Oku T
- Issue date: 1991 Mar
- [The analgesic effect of calcitonin on breast cancer patients with bone metastases].
- Authors: Kimura M, Abe R
- Issue date: 1987 Jul
- [Clinical study of a synthetic calcitonin derivative (elcatonin) in patients with metastatic bone tumors].
- Authors: Okayasu T, Masuda T, Hashimoto M, Tanabe T
- Issue date: 1987 Sep
- [Calcitonin in bone-metastasizing breast carcinoma. Results of a pilot study].
- Authors: Beaufort F, Gölles M
- Issue date: 1984 Jun